A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Ghia, P., Skarbnik, A., Miranda, M., Yong, A. S., Roos, J., Hettle, R., Palazuelos‐Munoz, S., Shetty, V., Kittai, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Ghia, P., Skarbnik, A., Miranda, M., Yong, A. S., Roos, J., Hettle, R., Palazuelos‐Munoz, S., Shetty, V., Kittai, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Ghia, P, Skarbnik, A, Miranda, M, Yong, A S, Roos, J, Hettle, R, Palazuelos-Munoz, S, Shetty, V, Kittai, A
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
HTA104 Opportunities to Improve the Adoption of Quality of Life Data as Part of the French Health Technology Assessment Process
Khalfallah Neelz, L, Larose, H, Lee, M, Grueger, J, Anota, A, Naiditch, N, Di Palma, M, Falissard, B, Palazuelos-Munoz, S, Tetafort, A
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article